PL398967A1 - The use of loganic acid in glaucoma therapy - Google Patents
The use of loganic acid in glaucoma therapyInfo
- Publication number
- PL398967A1 PL398967A1 PL398967A PL39896712A PL398967A1 PL 398967 A1 PL398967 A1 PL 398967A1 PL 398967 A PL398967 A PL 398967A PL 39896712 A PL39896712 A PL 39896712A PL 398967 A1 PL398967 A1 PL 398967A1
- Authority
- PL
- Poland
- Prior art keywords
- acid
- glaucoma therapy
- loganic acid
- loganic
- glaucoma
- Prior art date
Links
- JNNGEAWILNVFFD-DXNVVGTLSA-N 7-Epiloganic acid Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C(O)=O)C[C@@H](O)[C@@H]2C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JNNGEAWILNVFFD-DXNVVGTLSA-N 0.000 title abstract 2
- 208000010412 Glaucoma Diseases 0.000 title abstract 2
- WMQIBEYREGDWOS-UOUCRYGSSA-N Loganic acid Natural products CC[C@H]1O[C@@H](O[C@@H]2OC=C([C@H]3C[C@H](O)[C@H](C)[C@@H]23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O WMQIBEYREGDWOS-UOUCRYGSSA-N 0.000 title abstract 2
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 title abstract 2
- JNNGEAWILNVFFD-UHFFFAOYSA-N epiloganic acid Natural products CC1C(O)CC(C(=CO2)C(O)=O)C1C2OC1OC(CO)C(O)C(O)C1O JNNGEAWILNVFFD-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004410 intraocular pressure Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem wynalazku jest zastosowanie kwasu sloganowego do wytwarzania leku lub wyrobu medycznego do stosowania w terapii jaskry. Substancja czynna jest kwas loganowy o wzorze 1, którego dzialanie polega na obnizaniu cisnienia wewnatrzgalkowego i zwiekszeniu przeplywów w naczyniach krwionosnych oczu.The present invention relates to the use of sloganic acid in the manufacture of a medicament or medical device for use in the treatment of glaucoma. The active substance is loganic acid formula 1, which works by lowering intraocular pressure and increasing the flow of blood in the eye vessels.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL398967A PL222033B1 (en) | 2012-04-24 | 2012-04-24 | The use of loganic acid in the treatment of glaucoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL398967A PL222033B1 (en) | 2012-04-24 | 2012-04-24 | The use of loganic acid in the treatment of glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL398967A1 true PL398967A1 (en) | 2013-10-28 |
| PL222033B1 PL222033B1 (en) | 2016-06-30 |
Family
ID=49449315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL398967A PL222033B1 (en) | 2012-04-24 | 2012-04-24 | The use of loganic acid in the treatment of glaucoma |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL222033B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115607589B (en) * | 2020-04-24 | 2024-06-04 | 广州岐微生物医药科技有限公司 | Application of gentiana macrophylla and monomer compound thereof in mite killing |
-
2012
- 2012-04-24 PL PL398967A patent/PL222033B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL222033B1 (en) | 2016-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY171920A (en) | Prevention and treatment of ocular conditions | |
| MY175997A (en) | Antl-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition | |
| BR112015021334A2 (en) | Ocular formulations for drug delivery to the posterior segment of the eye | |
| PH12016500433B1 (en) | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine | |
| EA201391029A1 (en) | OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS | |
| SG10201804746WA (en) | Surgical methods employing purified amphiphilic peptide compositions | |
| MX2016009063A (en) | PHARMACEUTICAL PREPARATION CONTAINING PYRIDYLAMINOACETIC ACID COMPOUND. | |
| BR112014010376A2 (en) | medicament for treating anterior eye disease comprising rebamipide and a tear retention agent | |
| IN2014KN02617A (en) | ||
| MX2014000781A (en) | FIXED COMBINED DOSAGE OF BIMATOPROST AND BRIMONIDINE. | |
| BR112017023170A2 (en) | medicinal bath device and its use | |
| MX2018001918A (en) | PERIORBITAL QUANTITATIVE APPLICATION OF OPHTHALMOLOGICAL PHARMACOS. | |
| JP2013534527A5 (en) | ||
| IN2014CN04809A (en) | ||
| UA113966C2 (en) | WATER LIQUID PHARMACEUTICAL COMPOSITION CONTAINING ARBECACIN | |
| SG11201408323RA (en) | Prophylactic and/or therapeutic agent for mild cognitive impairment | |
| MX2015014939A (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias. | |
| UA108975C2 (en) | APPLICATION OF THE Copolymer of Sodium Carboxymethylcellulose and Gosipol in Complex Therapy of Patients with Autistic Disorders and Cogniitis | |
| PL398967A1 (en) | The use of loganic acid in glaucoma therapy | |
| NZ702666A (en) | A method of weight reduction | |
| EA201200466A1 (en) | THERAPEUTIC GAS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS | |
| GB201107576D0 (en) | Novel compounds and methods for use in medicine | |
| PL406517A1 (en) | Application of kynurenic acid and its salts and pharmaceutical composition | |
| NZ740627A (en) | Oral suspension for treating eosinophilic esophagitis | |
| RU2010131158A (en) | METHOD FOR PREVENTION OF RADIATING INJURIES TO DEHEATING WAYS |